Strategic Perspectives 2001: Ovarian Cancer - Overview of Current and New Developments, provides comprehensive insight into future changes in the ovarian cancer market, with an overview of the disease and current treatments, followed by in-depth analysis of the ovarian cancer pipeline by development strategy, drug class, region and company type, and concluding with forecasts of the likely impact these new drugs will have on the future market.
